Mraz Amerine & Associates’s MetLife MET Stock Holding History

Mraz Amerine & Associates’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,134	Closed	-$232K	–	174
2024 Q1	$232K	Sell	3,134 -183	-6%	-$12.8K	0.04%	153
2023 Q4	$219K	Sell	3,317 -1,000	-23%	-$62.6K	0.05%	158
2023 Q3	$272K	Sell	4,317 -595	-12%	-$37.1K	0.06%	145
2023 Q2	$278K	Hold	4,912	–	–	0.07%	137
2023 Q1	$285K	Sell	4,912 -650	-12%	-$43.9K	0.07%	136
2022 Q4	$403K	Hold	5,562	–	–	0.09%	116
2022 Q3	$338K	Hold	5,562	–	–	0.09%	119
2022 Q2	$349K	Hold	5,562	–	–	0.09%	118
2022 Q1	$391K	Hold	5,562	–	–	0.09%	121
2021 Q4	$348K	Hold	5,562	–	–	0.09%	124
2021 Q3	$343K	Sell	5,562 -300	-5%	-$18.1K	0.09%	129
2021 Q2	$351K	Sell	5,862 -500	-8%	-$31.7K	0.1%	126
2021 Q1	$387K	Hold	6,362	–	–	0.11%	108
2020 Q4	$299K	Hold	6,362	–	–	0.1%	118
2020 Q3	$236K	Hold	6,362	–	–	0.09%	119
2020 Q2	$232K	Buy	+6,362	New	+$221K	0.09%	115
2020 Q1	–	Sell	-6,462	Closed	-$329K	–	169
2019 Q4	$329K	Hold	6,462	–	–	0.09%	119
2019 Q3	$305K	Hold	6,462	–	–	0.09%	116
2019 Q2	$321K	Hold	6,462	–	–	0.1%	118
2019 Q1	$275K	Sell	6,462 -3,940	-38%	-$174K	0.09%	129
2018 Q4	$427K	Hold	10,402	–	–	0.14%	90
2018 Q3	$486K	Hold	10,402	–	–	0.14%	99
2018 Q2	$454K	Hold	10,402	–	–	0.14%	103
2018 Q1	$477K	Buy	10,402 +74	+0.7%	+$3.59K	0.15%	89
2017 Q4	$522K	Sell	10,328 -431	-4%	-$22.7K	0.16%	87
2017 Q3	$559K	Sell	10,759 -2,603	-19%	-$127K	0.18%	82
2017 Q2	$654K	Hold	13,362	–	–	0.2%	73
2017 Q1	$617K	Sell	13,362 -1,145	-8%	-$54.6K	0.19%	75
2016 Q4	$697K	Buy	14,507 +813	+6%	+$37.3K	0.22%	65
2016 Q3	$542K	Hold	13,694	–	–	0.19%	78
2016 Q2	$486K	Hold	13,694	–	–	0.17%	84
2016 Q1	$536K	Sell	13,694 -1,122	-8%	-$41.9K	0.2%	72
2015 Q4	$637K	Sell	14,816 -337	-2%	-$14.8K	0.24%	62
2015 Q3	$637K	Hold	15,153	–	–	0.25%	62
2015 Q2	$756K	Hold	15,153	–	–	0.28%	59
2015 Q1	$683K	Hold	15,153	–	–	0.26%	67
2014 Q4	$730K	Hold	15,153	–	–	0.28%	60
2014 Q3	$725K	Buy	15,153 +225	+2%	+$10.9K	0.28%	63
2014 Q2	$739K	Hold	14,928	–	–	0.29%	60
2014 Q1	$703K	Hold	14,928	–	–	0.29%	55
2013 Q4	$717K	Hold	14,928	–	–	0.32%	52
2013 Q3	$625K	Hold	14,928	–	–	0.3%	52
2013 Q2	$609K	Buy	+14,928	New	+$549K	0.31%	55

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Mraz Amerine & Associates's MET Position: Q2 2024 in Review

Mraz Amerine & Associates sold out of MetLife (MET) in Q2 2024, closing a stake of 3,134 shares — an estimated $232K sold.

Mraz Amerine & Associates first reported a position in MET in Q2 2013 and held it in 43 quarters. The position peaked at $756K in Q2 2015. 1,299 funds tracked by Wall St. Rank hold MET as of Q2 2024.

Mraz Amerine & Associates reported no remaining MetLife position as of Q2 2024 after selling out during the quarter.
Mraz Amerine & Associates sold 3,134 MetLife shares in Q2 2024, an estimated $232K.
Mraz Amerine & Associates first reported a position in MetLife in Q2 2013 and held it in 43 quarters.
Mraz Amerine & Associates's MetLife position peaked at $756K in Q2 2015.
1,299 funds tracked by Wall St. Rank held MetLife as of Q2 2024.

Based on Mraz Amerine & Associates's 13F filing for Q2 2024, filed 1 Aug 2024.